Cargando…
Selective serotonin reuptake inhibitor escitalopram inhibits 5-HT(3) receptor currents in NCB-20 cells
Escitalopram is one of selective serotonin reuptake inhibitor antidepressants. As an S-enantiomer of citalopram, it shows better therapeutic outcome in depression and anxiety disorder treatment because it has higher selectivity for serotonin reuptake transporter than citalopram. The objective of thi...
Autores principales: | Park, Yong Soo, Sung, Ki-Wug |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819908/ https://www.ncbi.nlm.nih.gov/pubmed/31680773 http://dx.doi.org/10.4196/kjpp.2019.23.6.509 |
Ejemplares similares
-
Gastroprokinetic agent, mosapride inhibits 5-HT(3) receptor currents in NCB-20 cells
por: Park, Yong Soo, et al.
Publicado: (2019) -
Lamotrigine, an antiepileptic drug, inhibits 5-HT(3) receptor currents in NCB-20 neuroblastoma cells
por: Kim, Ki Jung, et al.
Publicado: (2017) -
Tricyclic antidepressant amitriptyline inhibits 5-hydroxytryptamine 3 receptor currents in NCB-20 cells
por: Park, Yong Soo, et al.
Publicado: (2018) -
Escitalopram, a selective serotonin reuptake inhibitor, inhibits voltage-dependent K(+) channels in coronary arterial smooth muscle cells
por: Kim, Han Sol, et al.
Publicado: (2017) -
Effect of Proton Pump Inhibitors on the Serum Concentrations of the Selective Serotonin Reuptake Inhibitors Citalopram, Escitalopram, and Sertraline
por: Gjestad, Caroline, et al.
Publicado: (2015)